Examining the practical significance of reporting patient deaths due to main disease progression.
Lisa Carlson
Advertisement
Articles by Lisa Carlson
Advertisement
Latest Updated Articles
Death Waivers Draw an Incomplete Picture of Drug SafetyPublished: August 18th 2015 | Updated:
- Death Waivers an Incomplete Picture of Drug Safety
Published: October 1st 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
2
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
3
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
4
Operational and Governance Barriers to Regulatory-Grade RWE
5